| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 02/02/2012 | WO2012013716A1 Bicyclic acetyl-coa carboxylase inhibitors |
| 02/02/2012 | US20120029190 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| 02/02/2012 | US20120028987 Bicyclic Benzamides of 3-Or-4-Substituted 4-(Aminomethyl)-Piperidine Derivatives |
| 02/02/2012 | US20120028969 Bicyclic acetyl-coa carboxylase inhibitors and uses thereof |
| 02/02/2012 | US20120028804 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 02/01/2012 | EP2411397A1 Isothiazolo-pyrimidinedione derivatives as trpa1 modulators |
| 02/01/2012 | CN102341394A Poly (ADP-Ribose) Polymerase (PARP) Inhibitors |
| 01/31/2012 | US8106215 3-aza-bicyclo[3.3.0]octane compounds |
| 01/31/2012 | US8106041 Combination product comprising an antagonist or inverse agonist of histamine receptor H3 and an antipsychotic and antidepressant agent, and use thereof for the preparation of a medicament that prevents the adverse effects of psychotropic drugs |
| 01/26/2012 | WO2012012642A1 Tricyclic compounds and methds of making and using same |
| 01/26/2012 | WO2012011591A1 Fused heterocyclic compound and application thereof |
| 01/26/2012 | US20120022254 Sirtuin modulating compounds |
| 01/26/2012 | US20120022053 Oxadiazine Derivatives |
| 01/26/2012 | CA2806258A1 Fused heterocyclic compound and application thereof |
| 01/26/2012 | CA2806221A1 Tricyclic compounds and methds of making and using same |
| 01/25/2012 | EP2410002A1 Compound and element using same |
| 01/25/2012 | EP2408769A1 Pyrimidine derivatives used as itk inhibitors |
| 01/25/2012 | EP2328890B1 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors |
| 01/25/2012 | CN102333779A Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use |
| 01/25/2012 | CN102333776A Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof |
| 01/25/2012 | CN101410393B Novel heteroaryl substituted benzothiazoles |
| 01/24/2012 | US8101764 MCH receptor antagonists |
| 01/24/2012 | CA2509088C Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 01/19/2012 | WO2012009137A1 Crth2 modulators |
| 01/19/2012 | WO2012009001A2 Novel tetrahydropyrazolo[3,4-b]azepine derivatives and their use as allosteric modulators of metabotropic glutamate receptors |
| 01/19/2012 | WO2012008999A2 Tricyclic compounds as allosteric modulators of metabotropic glutamate receptors |
| 01/19/2012 | WO2012007510A1 Compounds for binding and imaging amyloid plaques and their use |
| 01/19/2012 | WO2012006760A1 Tricyclic compounds as allosteric modulators of metabotropic glutamate receptors |
| 01/19/2012 | US20120015941 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds |
| 01/19/2012 | US20120015928 Amido Compounds And Their Use As Pharmaceuticals |
| 01/19/2012 | US20120015926 Compounds for the treatment of inflammatory disorders |
| 01/19/2012 | CA2807318A1 Novel tetrahydropyrazolo[3,4-b]azepine derivatives and their use as allosteric modulators of metabotropic glutamate receptors |
| 01/19/2012 | CA2805724A1 Organic compounds |
| 01/18/2012 | EP2407457A1 Process for producing diamine derivative |
| 01/18/2012 | EP2407450A1 Method for producing optically active diamine derivative |
| 01/18/2012 | EP2405973A2 Thiazolopyrimidine modulators as immunosuppressive agents |
| 01/18/2012 | CN102325780A 6-phenyl-2-[((piperidin-4-ylmethyl)-piperazin-1yl) or piperazin 1-ylmethyl)-piperidin-1-yl)]-imidazo[2,1-b][1,3,4]thiadiazole derivatives and their use |
| 01/18/2012 | CN102325528A Activated blood coagulation factor X (FXa) inhibitor |
| 01/18/2012 | CN102321103A 5-methyl-1,2,4-triazole[3,4-b]benzothiazole derivative and application thereof |
| 01/18/2012 | CN102321102A N2,N4-disubstituted-2H,4H-pyrrole[1,2-b][1,2,4,6] thiatriazine-1,1,3-triketone derivatives as well as preparation and application thereof |
| 01/17/2012 | US8097643 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 01/17/2012 | US8097628 Compounds |
| 01/17/2012 | US8097613 [1,2,4]thiadiazine 1,1-dioxide compounds |
| 01/17/2012 | US8097611 Sulfonyl-derivatives as novel or histone deacetylase |
| 01/17/2012 | US8097607 loading-dose regimen; an initial administration of rifalazil for 4 to 14 days, followed by less than half this average daily dose for the subsequent 4 to 14 days |
| 01/17/2012 | CA2558139C Tricyclic benzopyran compound as anti-arrhythmic agents |
| 01/12/2012 | WO2012006203A1 N-cyclyl-3 - (cyclylcarbonylaminomethyl) benzamide derivatives as rho kinase inhibitors |
| 01/12/2012 | WO2012006202A1 Rho kinase inhibitors |
| 01/12/2012 | WO2012004604A1 Tetrazole compounds as calcium channel blockers |
| 01/12/2012 | WO2012004373A1 Fused heterocyclic derivatives as s1p modulators |
| 01/12/2012 | WO2010135524A8 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases |
| 01/12/2012 | US20120009519 Compound, resin and photoresist composition |
| 01/12/2012 | CA2804137A1 Fused heterocyclic derivatives as s1p modulators |
| 01/11/2012 | EP1991549B1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators |
| 01/11/2012 | EP1566380B1 Isoquinoline compounds and medicinal use thereof |
| 01/11/2012 | CN102317293A RAF inhibitors and their uses |
| 01/11/2012 | CN102311423A Preparation method and application of novel antibacterial and anticancer compounds |
| 01/11/2012 | CN102311405A Organic material and organic light emitting device including the same |
| 01/11/2012 | CN101146811B Hiv integrase inhibitors |
| 01/10/2012 | US8093390 Substituted fused [1,2]imidazo[4,5-C] ring compounds and methods |
| 01/10/2012 | US8093382 Dipeptidyl peptidase inhibitors |
| 01/10/2012 | US8093240 Triazole derivatives |
| 01/10/2012 | US8093238 Fused thiazole derivatives as kinase inhibitors |
| 01/10/2012 | US8093235 Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA |
| 01/05/2012 | WO2012002577A1 Novel nicotinamide derivatives or salts thereof |
| 01/05/2012 | WO2012002538A1 Process for preparation of optically active diamine derivative salt |
| 01/05/2012 | WO2012001486A1 An improved process for the preparation of prasugrel hydrochloride and its intermediates |
| 01/05/2012 | WO2012001357A1 Crystalline form of prulifloxacin and processes for its preparation |
| 01/05/2012 | US20120004221 Antibacterial Compositions |
| 01/05/2012 | CA2804262A1 Process for preparation of optically active diamine derivative salt |
| 01/05/2012 | CA2803842A1 Novel nicotinamide derivative or salt thereof |
| 01/04/2012 | EP2402340A1 Pyrazolopyridine compounds |
| 01/04/2012 | EP2402327A1 Acetamide compounds as glucokinase activators, their process and medicinal applications |
| 01/04/2012 | EP2402310A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2402309A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2401283A1 6-phenyl-2-ý((piperidin-4-ylmethyl)-piperazin-1yl) or piperazin 1-ylmethyl)-piperidin-1-yl)¨-imidazoý2,1-b¨ý1,3,4¨thiadiazole derivatives and their use |
| 01/04/2012 | EP2401273A1 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 01/04/2012 | EP1986645B1 Glucokinase activators |
| 01/04/2012 | EP1833827B9 Process for preparing 2-methyl-1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine |
| 01/04/2012 | CN102307882A Stem cell cultures |
| 01/04/2012 | CN101522693B Novel 5,7-disubstituted [1, 3] thiazolo [4, 5] pyrimidin-2 (3h)-amine deirvatives and their use in therapy |
| 01/03/2012 | US8088917 Ionic liquids |
| 01/03/2012 | CA2636077C Thiazole compounds as protein kinase b (pkb) inhibitors |
| 01/03/2012 | CA2512441C Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 01/03/2012 | CA2397661C 2,4-disubstituted thiazolyl derivatives |
| 12/29/2011 | WO2011125006A3 Sultam compounds |
| 12/29/2011 | US20110319434 Bicyclic Heterocyclic Derivatives and Methods of Use Thereof |
| 12/29/2011 | US20110319425 Heterotricyclic compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 12/29/2011 | US20110319398 Inhibition of yops translocation |
| 12/28/2011 | EP2399921A1 Heterocyclic compound and use thereof |
| 12/28/2011 | EP2399903A1 Ccr9 inhibitors and methods of use thereof |
| 12/28/2011 | EP2398810A1 Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase |
| 12/28/2011 | EP2178858B1 Novel heterocyclic compounds as mglu5 antagonists |
| 12/28/2011 | CN102295756A 含咔唑卟啉-噻吩并噻二唑共聚物及其制备方法和应用 Carbazole containing porphyrin - thiophene and thiadiazole copolymer and its preparation method and application |
| 12/28/2011 | CN101568536B 作为食欲素受体拮抗剂的2-氮杂-双环[3.1.0]己烷衍生物 As orexin receptor antagonists 2-aza - bicyclo [3.1.0] hexane derivatives |
| 12/27/2011 | US8084472 Fused pyrrolocarbazoles |
| 12/27/2011 | US8084210 Methods for the assessment of drug response |
| 12/22/2011 | WO2011157827A1 Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
| 12/22/2011 | US20110313000 Ccr9 inhibitors and methods of use thereof |
| 12/22/2011 | US20110312991 Activated blood coagulation factor inhibitor |